Back to Journals » OncoTargets and Therapy » Volume 17

Metformin Suppresses the Proliferation and Promotes the Apoptosis of Colon Cancer Cells Through Inhibiting the Expression of Long Noncoding RNA-UCA1 [Retraction]

Authors Guo J, Li Y, Duan H, Yuan L 

Received 24 January 2024

Accepted for publication 24 January 2024

Published 26 January 2024 Volume 2024:17 Pages 33—34

DOI https://doi.org/10.2147/OTT.S461190



Guo J, Li Y, Duan H, Yuan L. Onco Targets Ther. 2020;13:4169-4181.

We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.

Following publication of the article, concerns were raised about the duplication of images from Figure 6 with images from other unrelated articles. Specifically,

  • Images for Figure 6C have been duplicated with images for Figure 6D from Luo Q, Li B, Li G. Mannose Suppresses the Proliferation and Metastasis of Lung Cancer by Targeting the ERK/GSK-3β/β-Catenin/SNAIL Axis. Onco Targets Ther. 2020;13:2771-2781. https://doi.org/10.2147/OTT.S241816.

The authors responded to our queries but were unable to provide a sufficient explanation for the duplicated images or provide sufficient data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors agree with this decision.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.